NUVAXOVID
Google image searchProduct monograph
Active ingredient
sars-cov-2 recombinant spike protein, 5 MCG/0.5 ML
DIN: 02543656
Dosage form(s): SUSPENSION
Route(s) of administration: INTRAMUSCULAR
Description: MULTIDOSE VIAL (VIAL CONTAINS 5 DOSES OF 0.5ML)
Schedule: Schedule D
Company: NOVAVAX INC.
Date: 19-SEP-2024
ATC:
- J07 — VACCINES (ATC, ATC/DDD, )
- J07B — VIRAL VACCINES (ATC, ATC/DDD)
- J07BN — Covid-19 vaccines (ATC, ATC/DDD)
- J07BN04 — COVID-19, PROTEIN SUBUNIT (ATC/DDD)
Reference brand drug: Nuvaxovid
